Connection

Maria Sormani to Adult

This is a "connection" page, showing publications Maria Sormani has written about Adult.
Connection Strength

0.153
  1. DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France. Ann Clin Transl Neurol. 2021 08; 8(8):1738-1744.
    View in: PubMed
    Score: 0.016
  2. Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis. Ann Neurol. 2021 04; 89(4):780-789.
    View in: PubMed
    Score: 0.015
  3. Cerebellar volume as imaging outcome in progressive multiple sclerosis. PLoS One. 2017; 12(4):e0176519.
    View in: PubMed
    Score: 0.012
  4. Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets. Mult Scler. 2018 02; 24(2):222-226.
    View in: PubMed
    Score: 0.012
  5. Assessing long-term prognosis improvement as a consequence of treatment pattern changes in MS. Mult Scler. 2017 Nov; 23(13):1757-1761.
    View in: PubMed
    Score: 0.012
  6. Effect of fingolimod on diffuse brain tissue damage in relapsing-remitting multiple sclerosis patients. Mult Scler Relat Disord. 2016 May; 7:98-101.
    View in: PubMed
    Score: 0.011
  7. The outcome of a national MS-Covid-19 study: What the Turkish MS cohort reveals? Mult Scler Relat Disord. 2021 Jul; 52:102968.
    View in: PubMed
    Score: 0.004
  8. Tocilizumab and steroid treatment in patients with COVID-19 pneumonia. PLoS One. 2020; 15(8):e0237831.
    View in: PubMed
    Score: 0.004
  9. Adherence to social distancing and use of personal protective equipment and the risk of SARS-CoV-2 infection in a cohort of patients with multiple sclerosis. Mult Scler Relat Disord. 2020 Oct; 45:102359.
    View in: PubMed
    Score: 0.004
  10. Different MRI patterns in MS worsening after stopping fingolimod. Neurol Neuroimmunol Neuroinflamm. 2019 07; 6(4):e566.
    View in: PubMed
    Score: 0.003
  11. Revised upper limb module for spinal muscular atrophy: 12 month changes. Muscle Nerve. 2019 04; 59(4):426-430.
    View in: PubMed
    Score: 0.003
  12. Increased incidence of axonal Guillain-Barré syndrome in La Spezia area of Italy: A 13-year follow-up study. J Peripher Nerv Syst. 2019 03; 24(1):80-86.
    View in: PubMed
    Score: 0.003
  13. A prospective comparative trial of adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts (ASTOUND-2). Eur J Cancer. 2018 11; 104:39-46.
    View in: PubMed
    Score: 0.003
  14. Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndrome. Eur J Neurol. 2019 01; 26(1):162-167.
    View in: PubMed
    Score: 0.003
  15. Clinical activity after fingolimod cessation: disease reactivation or rebound? Eur J Neurol. 2018 10; 25(10):1270-1275.
    View in: PubMed
    Score: 0.003
  16. Within-patient fluctuation of brain volume estimates from short-term repeated MRI measurements using SIENA/FSL. J Neurol. 2018 May; 265(5):1158-1165.
    View in: PubMed
    Score: 0.003
  17. Estimates of age-dependent cutoffs for pathological brain volume loss using SIENA/FSL-a longitudinal brain volumetry study in healthy adults. Neurobiol Aging. 2018 05; 65:1-6.
    View in: PubMed
    Score: 0.003
  18. Long-term disability progression in primary progressive multiple sclerosis: a 15-year study. Brain. 2017 Nov 01; 140(11):2814-2819.
    View in: PubMed
    Score: 0.003
  19. Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study. Neurology. 2017 Nov 28; 89(22):2222-2229.
    View in: PubMed
    Score: 0.003
  20. To do or not to do? plasma exchange and timing of steroid administration in progressive multifocal leukoencephalopathy. Ann Neurol. 2017 Nov; 82(5):697-705.
    View in: PubMed
    Score: 0.003
  21. Quantitative assessment of finger motor performance: Normative data. PLoS One. 2017; 12(10):e0186524.
    View in: PubMed
    Score: 0.003
  22. Steroid treatment of acute graft-versus-host disease grade I: a randomized trial. Haematologica. 2017 12; 102(12):2125-2133.
    View in: PubMed
    Score: 0.003
  23. Trans-synaptic degeneration in the optic pathway. A study in clinically isolated syndrome and early relapsing-remitting multiple sclerosis with or without optic neuritis. PLoS One. 2017; 12(8):e0183957.
    View in: PubMed
    Score: 0.003
  24. Three-Dimensional Shape and Surface Features Distinguish Multiple Sclerosis Lesions from Nonspecific White Matter Disease. J Neuroimaging. 2017 11; 27(6):613-619.
    View in: PubMed
    Score: 0.003
  25. Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis. Mult Scler. 2018 04; 24(5):642-652.
    View in: PubMed
    Score: 0.003
  26. Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis. JAMA Neurol. 2017 Apr 01; 74(4):459-469.
    View in: PubMed
    Score: 0.003
  27. No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML. Neurology. 2017 03 21; 88(12):1144-1152.
    View in: PubMed
    Score: 0.003
  28. MRI FLAIR lesion segmentation in multiple sclerosis: Does automated segmentation hold up with manual annotation? Neuroimage Clin. 2017; 13:264-270.
    View in: PubMed
    Score: 0.003
  29. Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers. Ann Rheum Dis. 2015 May; 74(5):799-805.
    View in: PubMed
    Score: 0.003
  30. Age independently affects myelin integrity as detected by magnetization transfer magnetic resonance imaging in multiple sclerosis. Neuroimage Clin. 2014; 4:641-8.
    View in: PubMed
    Score: 0.002
  31. Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysis. J Neurol Neurosurg Psychiatry. 2000 Dec; 69(6):723-7.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.